Low-dose rituximab protocol in rheumatoid arthritis—outcome and economic impact

OBJECTIVES: A significant proportion of RA patients, particularly those associated with poor prognostic factors, fail on conventional DMARDs (cDMARDs). Although rituximab (RTX) has been effective in these patients, the cost of therapy makes it unaffordable, particularly in poor and developing countr...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatol Adv Pract
Main Authors: Chandramohan, Parvathypriya, Jain, Avinash, Antony, Glindow, Krishnan, Narayanan, Shenoy, Padmanabha
Format: Artigo
Language:Inglês
Published: Oxford University Press 2021
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7878847/
https://ncbi.nlm.nih.gov/pubmed/33605940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa077
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items